ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1171

Evidence of Subclinical Joint Inflammation of Hands by Magnetic Resonance Imaging in Patients with Psoriatic Arthritis in Minimal Disease Activity – Interim Analysis

Victoria Furer1, Ari Polachek 2, Liran Mendel 1, David Levartovsky 3, Jonathan Wollman 4, Valerie Aloush 5, Ilana Kaufman 6, Hagit Sarbagil-Maman 7, Sara Borok 6, Mark Berman 6, Adi Broyde 6, Yael Lahat 1, Mirna Zureik 1, Sharon Nevo 1, Daphna Paran 6, Iris Eshed 8 and Ori Elkayam 6, 1Sourasky Medical Center, Tel-Aviv, Israel, 2Tel-Aviv Sourasky medical center, Tel Aviv, Israel, 3Sourasky medical center, Tel Aviv, Israel, 4Sourasky Medical Center, Herzelia, Israel, 5Tel Aviv Sourasky medical center, Tel Aviv, 6Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 7Tel-Aviv Sourasky medical center, Qiryat-Ono, Israel, 8Sheba Medical Center, Tel Aviv, Israel

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Magnetic resonance imaging (MRI), Psoriatic arthritis, remission and synovitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: Imaging Of Rheumatic Diseases Poster II

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Subclinical inflammatory lesions detected by MRI are prevalent in hand joints of patients with cutaneous psoriasis (1). Yet, it is unknown whether these inflammatory changes persist in patients with psoriatic arthritis (PsA) in low disease activity/clinical remission. Minimal disease activity (MDA) is a validated composite index used for clinical evaluation in PsA(2). The purpose of this study is to estimate the prevalence of hand inflammatory changes in PsA patients with MDA versus non-MDA (active disease) using MRI.

Methods: Sixty consecutive prospectively recruited patients with peripheral PsA (CASPAR criteria) underwent clinical evaluation, questionnaires, and MRI of a predominantly involved hand within 72 hours of the clinical examination. MRI scans were scored for synovitis, tenosynovitis, periarticular inflammation, bone edema, bone erosion, and bone proliferation according to the OMERACT PsA MRI scoring system (PsAMRIS) method(3), performed by an expert musculoskeletal radiologist, blinded for clinical data.

Results: Clinical characteristics of the PsA cohort and prevalence of hand MRI lesions are presented in Table 1. The mean total PsAMRIS of the cohort was low (5.5 units [SD 9.1]), with synovitis of MCP joints being the most common finding (n=27 patients, [45%]). PsA duration was moderately correlated with the total PsAMRIS (Spearman’s rank correlation rho 0.358, p=0.005).

MDA (n=19) and non-MDA (n=41) groups were comparable in age, BMI, psoriasis/PsA duration, skin disease severity, and treatment modalities. (Table 2) Total PsAMRIS units (mean [SD]) was similar in MDA and non-MDA groups: 6.1 [11.14] vs 6.1 [7.4], respectively (p=0.985). Remarkably, both groups had a similar prevalence of hand synovitis with predominant involvement of MCP joints: MDA vs non-MDA, n=8 [42.1%] vs 19 [46.3%], p=0.978. The prevalence of bone marrow edema, periarticular inflammation, and bone erosions was higher in the non-MDA group but did not reach statistical significance: MDA vs non-MDA, n=3 [15.8%] vs 10 [24.4%], p=0.678; n=1 [5.3%] vs 7 [17.1%], p=0.399; n=2 [10.5%] vs 6 [14.6%], p=0.978, respectively. Flexor tenosynovitis was detected only in the non-MDA group (n=10.0, [24%], p=0.047), whereas bone proliferation was detected only in the MDA group (n=3 [15.8%], p=0.048). Comparison of the prevalence of inflammatory MRI findings by grouping the extent of synovitis, bone marrow edema, and periarticular inflammation by severity did not change the results.

Conclusion: This preliminary study results corroborate a high proportion of subclinical inflammation detected by MRI in joints of hand in PsA patients in MDA, whereas overall PsAMRIS scores were low in both MDA and non-MDA groups. These results need to be reproduced in a larger cohort.

References:

  1. Faustini F. Ann Rheum Dis. 2016;75.
  2. Coates LC. Ann Rheum Dis. 2010;69. 
  3. Ostergaard M. J Rheumatol 2003;30.


Table 1

Table 1. Clinical characteristics and MRI findings in the PsA cohort -n=60-.


Table 2

Table 2. Clinical characteristics and prevalence of MRI lesions of hands in patients with psoriatic arthritis stratified by minimal disease activity -MDA-.


Disclosure: V. Furer, None; A. Polachek, None; L. Mendel, None; D. Levartovsky, None; J. Wollman, None; V. Aloush, None; I. Kaufman, None; H. Sarbagil-Maman, None; S. Borok, None; M. Berman, None; A. Broyde, None; Y. Lahat, None; M. Zureik, None; S. Nevo, None; D. Paran, None; I. Eshed, None; O. Elkayam, None.

To cite this abstract in AMA style:

Furer V, Polachek A, Mendel L, Levartovsky D, Wollman J, Aloush V, Kaufman I, Sarbagil-Maman H, Borok S, Berman M, Broyde A, Lahat Y, Zureik M, Nevo S, Paran D, Eshed I, Elkayam O. Evidence of Subclinical Joint Inflammation of Hands by Magnetic Resonance Imaging in Patients with Psoriatic Arthritis in Minimal Disease Activity – Interim Analysis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/evidence-of-subclinical-joint-inflammation-of-hands-by-magnetic-resonance-imaging-in-patients-with-psoriatic-arthritis-in-minimal-disease-activity-interim-analysis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evidence-of-subclinical-joint-inflammation-of-hands-by-magnetic-resonance-imaging-in-patients-with-psoriatic-arthritis-in-minimal-disease-activity-interim-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology